These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 5875220)

  • 21. The pharmacist and adverse drug reaction reporting.
    Pearson K
    Hosp Pharm; 1982 Aug; 17(8):421-2, 427-30. PubMed ID: 10256700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Today's requirements in food, drug and chemical control.
    Osterberg RE
    Acta Pharmacol Toxicol (Copenh); 1983; 52 Suppl 2():201-28. PubMed ID: 6880782
    [No Abstract]   [Full Text] [Related]  

  • 23. Implications of FDA's proposal to include foreign marketing experience in the over-the-counter drug review process.
    Pinco RG
    Food Drug Law J; 1998; 53(1):105-22. PubMed ID: 11795327
    [No Abstract]   [Full Text] [Related]  

  • 24. [Registration of the adverse effects of drugs].
    Buur J
    Sven Farm Tidskr; 1966 Oct; 70(30):720-3. PubMed ID: 5978632
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: Fatal reactions to drug therapy.
    Koch-Weser J
    N Engl J Med; 1974 Aug; 291(6):302-3. PubMed ID: 4407113
    [No Abstract]   [Full Text] [Related]  

  • 26. Health update on sulfites in food and drugs.
    Oberste DM
    J Ark Med Soc; 1984 Jul; 81(2):130-2. PubMed ID: 6236206
    [No Abstract]   [Full Text] [Related]  

  • 27. The planning of a national drug monitoring system.
    Esch AF
    World Health Organ Tech Rep Ser; 1972; 498():44-7. PubMed ID: 4625551
    [No Abstract]   [Full Text] [Related]  

  • 28. Pediatric drug information: food allergies, food additives, and the Feingold diet.
    Robinson LA
    Pediatr Nurs; 1980; 6(6):38-9. PubMed ID: 6904961
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA and veterinary practice philosophy of drug use.
    Knobloch CP
    J Am Vet Med Assoc; 1980 Jul; 177(1):34,38. PubMed ID: 7429937
    [No Abstract]   [Full Text] [Related]  

  • 30. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 31. Living with and reforming the Delaney Clause.
    Degnan FH; Flamm WG
    Food Drug Law J; 1995; 50(2):235-56. PubMed ID: 10342993
    [No Abstract]   [Full Text] [Related]  

  • 32. Science works through law to protect consumers. FDA's expanding horizons.
    Milstead KL
    J Am Diet Assoc; 1966 Mar; 48(3):187-91. PubMed ID: 5952176
    [No Abstract]   [Full Text] [Related]  

  • 33. The regulatory status of talc.
    Gilbertson WE
    Regul Toxicol Pharmacol; 1995 Apr; 21(2):230-2. PubMed ID: 7644710
    [No Abstract]   [Full Text] [Related]  

  • 34. Developing an adverse drug reaction reporting program.
    Nelson RW; Shane R
    Am J Hosp Pharm; 1983 Mar; 40(3):445-6. PubMed ID: 6846354
    [No Abstract]   [Full Text] [Related]  

  • 35. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug therapy monitoring notes--untapped source of data.
    Riddiough MA
    Am J Hosp Pharm; 1978 Mar; 35(3):241, 243. PubMed ID: 626202
    [No Abstract]   [Full Text] [Related]  

  • 37. Food and Drug Administration Advisory Committee on Protocols for Safety Evaluations. Panel on reproduction report on reporduction studies in the safety evaluation of food additives and pesticide residues.
    Toxicol Appl Pharmacol; 1970 Jan; 16(1):264-96. PubMed ID: 5467148
    [No Abstract]   [Full Text] [Related]  

  • 38. [International cooperation in assembling adverse drug effects. A scientific trial program as a pilot study of the World Health Organization].
    Homann G
    Zahnarztl Mitt; 1968 Jul; 58(13):635-6. PubMed ID: 5243097
    [No Abstract]   [Full Text] [Related]  

  • 39. [Food additives. A possible reason for drug complications-adverse effects?].
    Lokken P; Lunde PK
    Tidsskr Nor Laegeforen; 1972 Aug; 92(24):1541-3. PubMed ID: 5076544
    [No Abstract]   [Full Text] [Related]  

  • 40. Improving how we evaluate the toxicity of approved drugs.
    Reidenberg MM
    Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.